$593.20M
Revenue
$44.20M
Net Income
43.21%
Gross Margin
11.85%
Op. Margin
-
Free Cash Flow
| Breakdown | Q4 2025 (Dec 31, 2025) |
Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|---|
| Total Revenue | $162.20M | $152.90M | $145.90M | $132.20M | $142.50M | $142.50M | $204.70M |
| Revenue Growth % (YoY) | 13.8% | 7.3% | -28.7% | nan% | nan% | nan% | nan% |
| Cost of Revenue | $89.60M | $82.80M | $81.70M | $78.40M | $81.10M | $79.50M | $127.90M |
| Gross Profit | $72.50M | $69.90M | $60.60M | $53.30M | $60.90M | $62.90M | $77.60M |
| Gross Margin % | 44.7% | 45.7% | 41.5% | 40.3% | 42.7% | 44.1% | 37.9% |
| Operating Expenses | $46.70M | $44.10M | $45.90M | $49.30M | $45.50M | $44.20M | $313.20M |
| Research & Development | $10.50M | $10.00M | $10.00M | $9.70M | $10.30M | $10.20M | $20.90M |
| Selling General & Admin | $35.70M | $34.00M | $35.90M | $37.20M | $35.20M | $33.90M | $43.00M |
| Operating Income | $25.80M | $25.80M | $14.70M | $4.00M | $15.40M | $18.70M | $-235.60M |
| Operating Margin % | 15.9% | 16.9% | 10.1% | 3.0% | 10.8% | 13.1% | -115.1% |
| Interest Expense | $-2.00M | $6.20M | $4.20M | $2.20M | $-2.20M | $9.70M | $6.90M |
| Other Income/Expense | $-600.00K | $-1.20M | $-900.00K | $-500.00K | $1.70M | $-2.60M | $-300.00K |
| Income Before Tax | $29.60M | $22.30M | $11.30M | $800.00K | $13.70M | $12.20M | $-240.50M |
| Income Tax Expense | $4.10M | $4.30M | $3.50M | $1.20M | $3.30M | $3.00M | $18.80M |
| Net Income | $21.00M | $17.40M | $7.80M | $-2.00M | $18.50M | $500.00K | $-259.30M |
| Net Margin % | 12.9% | 11.4% | 5.3% | -1.5% | 13.0% | 0.4% | -126.7% |
| Basic EPS | 0.24 | 0.20 | 0.09 | -0.02 | 0.20 | 0.01 | -2.90 |
| Diluted EPS | 0.24 | 0.20 | 0.09 | -0.02 | 0.20 | 0.01 | -2.90 |
| Basic Shares Outstanding | - | 85.8M | 86.9M | 87.8M | -300K | 88.7M | 89.4M |
| Diluted Shares Outstanding | - | 87.3M | 87.6M | 87.8M | -100K | 89.7M | 89.4M |
| Breakdown | Q4 2025 (Dec 31, 2025) |
Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $54.20M | $92.50M | $103.20M | $101.90M | $130.10M | $92.60M | $84.00M |
| Accounts Receivable | $102.80M | $107.70M | $101.10M | $106.90M | $105.00M | $105.70M | $136.10M |
| Inventory | $124.60M | $123.90M | $119.70M | $120.00M | $118.00M | $124.90M | $190.10M |
| Other Current Assets | $9.80M | $10.10M | $10.80M | $9.10M | $8.30M | $9.80M | $12.70M |
| Total Current Assets | $291.40M | $334.20M | $334.80M | $337.90M | $361.40M | $436.00M | $422.90M |
| Property Plant & Equipment | $140.20M | $130.90M | $127.20M | $129.00M | $130.10M | $134.40M | $159.40M |
| Goodwill | $270.30M | $270.20M | $270.10M | $269.80M | $269.80M | $270.40M | $291.20M |
| Intangible Assets | $141.10M | $145.30M | $149.30M | $153.40M | $157.40M | $162.30M | $177.30M |
| Long-term Investments | $83.40M | $77.20M | $77.20M | $77.20M | $77.20M | - | - |
| Other Non-current Assets | $105.60M | $110.70M | $109.90M | $110.00M | $113.70M | $115.60M | $116.70M |
| Total Assets | $1.05B | $1.09B | $1.09B | $1.10B | $1.12B | $1.17B | $1.18B |
| Accounts Payable | $42.90M | $41.20M | $38.80M | $39.60M | $58.50M | $34.20M | $52.50M |
| Short-term Debt | - | - | - | - | $72.70M | - | - |
| Other Current Liabilities | - | $25.30M | $27.70M | $35.10M | - | $18.50M | $22.00M |
| Total Current Liabilities | $105.90M | $176.00M | $167.20M | $167.60M | $197.60M | $185.90M | $178.90M |
| Long-term Debt | $114.00M | $104.00M | $119.00M | $119.00M | $202.50M | $175.50M | $212.40M |
| Deferred Tax Liabilities | $1.10M | $1.10M | $1.10M | $1.10M | $1.10M | $800.00K | $800.00K |
| Other Non-current Liabilities | $38.20M | $38.40M | $37.70M | $36.30M | $23.70M | $24.00M | $26.10M |
| Common Stock | $1.00M | $1.00M | $1.00M | $1.00M | $1.00M | $1.00M | $1.00M |
| Retained Earnings | $-569.40M | $-590.40M | $-607.80M | $-615.60M | $-613.60M | $-632.10M | $-632.60M |
| Total Stockholders Equity | $775.80M | $751.80M | $746.10M | $755.80M | $756.00M | $777.40M | $753.00M |
| Total Liabilities & Equity | $1.05B | $1.09B | $1.09B | $1.10B | $1.12B | $1.17B | $1.18B |
| Breakdown | Q4 2025 (Dec 31, 2025) |
Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|---|
| Net Income | $21.00M | $17.40M | $7.80M | $-2.00M | $18.50M | $-256.30M | $-256.80M |
| Depreciation & Amortization | $9.20M | $27.10M | $18.10M | $9.00M | $9.60M | $40.70M | $27.40M |
| Stock-based Compensation | $6.00M | $22.40M | $16.50M | $10.20M | $1.40M | $21.40M | $14.10M |
| Change in Receivables | $-4.90M | $3.80M | $-2.80M | $3.10M | $-12.40M | $8.40M | $1.00M |
| Change in Inventory | $300.00K | $4.80M | $400.00K | $1.60M | $9.60M | $-11.20M | $-3.40M |
| Change in Payables | $2.80M | $-20.80M | $-20.80M | $-19.30M | $19.20M | $5.80M | $2.80M |
| Operating Cash Flow | - | $66.80M | $37.70M | $1.30M | - | $95.00M | $42.20M |
| Capital Expenditure | $15.30M | $16.80M | $9.10M | $4.00M | $3.30M | $10.30M | $6.60M |
| Investing Cash Flow | $-15.30M | $-16.30M | $-8.60M | $-3.50M | $48.30M | $-3.10M | $600.00K |
| Stock Repurchased | $10.00M | $55.00M | $35.00M | $5.00M | $24.20M | $29.50M | $25.00M |
| Financing Cash Flow | $-70.30M | $-88.60M | $-56.50M | $-26.20M | $-44.80M | $-87.20M | $-46.00M |
| Net Change in Cash | $-38.30M | $-37.60M | $-26.90M | $-28.20M | $37.50M | $5.30M | $-3.30M |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $152.90M | $142.50M | $431.00M | $411.00M |
| Cost of Revenue | $82.80M | $79.50M | $242.90M | $235.70M |
| Gross Profit | $69.90M | $62.90M | $183.80M | $173.90M |
| Operating Expenses | $44.10M | $44.20M | $139.30M | $137.50M |
| Research & Development | $10.00M | $10.20M | $29.70M | $29.20M |
| Selling General & Admin | $34.00M | $33.90M | $107.10M | $106.80M |
| Operating Income | $25.80M | $18.70M | $44.50M | $36.40M |
| Interest Expense | - | - | $6.20M | $9.70M |
| Other Income/Expense | $-1.20M | $-2.60M | $-2.60M | $-2.50M |
| Income Before Tax | $22.30M | $12.20M | $34.40M | $21.00M |
| Income Tax Expense | $4.30M | $3.00M | $9.00M | $8.00M |
| Net Income | $17.40M | $500.00K | $23.20M | $-256.30M |
| Basic EPS | 0.20 | 0.01 | 0.27 | -2.87 |
| Diluted EPS | 0.20 | 0.01 | 0.26 | -2.84 |
| Basic Shares Outstanding | $85.80M | $88.70M | $86.80M | $89.20M |
| Diluted Shares Outstanding | $87.30M | $89.70M | $88.10M | $90.20M |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Cash & Cash Equivalents | $92.50M | $130.10M |
| Accounts Receivable | $107.70M | $105.00M |
| Inventory | $123.90M | $118.00M |
| Other Current Assets | $10.10M | $8.30M |
| Total Current Assets | $334.20M | $361.40M |
| Property Plant & Equipment | $130.90M | $130.10M |
| Goodwill | $270.20M | $269.80M |
| Intangible Assets | $145.30M | $157.40M |
| Long-term Investments | $77.20M | $77.20M |
| Other Non-current Assets | $110.70M | $113.70M |
| Total Assets | $1.09B | $1.12B |
| Accounts Payable | $41.20M | $58.50M |
| Other Current Liabilities | $25.30M | $33.60M |
| Total Current Liabilities | $176.00M | $197.60M |
| Long-term Debt | $104.00M | $134.00M |
| Deferred Tax Liabilities | $1.10M | $1.10M |
| Other Non-current Liabilities | $38.40M | $23.70M |
| Common Stock | $1.00M | $1.00M |
| Retained Earnings | $-590.40M | $-613.60M |
| Total Stockholders Equity | $751.80M | $756.00M |
| Total Liabilities & Equity | $1.09B | $1.12B |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $17.40M | $500.00K | $23.20M | $-256.30M |
| Depreciation & Amortization | - | - | $27.10M | $40.70M |
| Stock-based Compensation | - | - | $22.40M | $21.40M |
| Change in Receivables | - | - | $3.80M | $8.40M |
| Change in Inventory | - | - | $4.80M | $-11.20M |
| Change in Payables | - | - | $-20.80M | $5.80M |
| Operating Cash Flow | - | - | $66.80M | $95.00M |
| Capital Expenditure | - | - | $16.80M | $10.30M |
| Investing Cash Flow | - | - | $-16.30M | $-3.10M |
| Stock Repurchased | - | - | $55.00M | $29.50M |
| Financing Cash Flow | - | - | $-88.60M | $-87.20M |
| Net Change in Cash | - | - | $-37.60M | $5.30M |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.
Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.